chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Kidney low back pain; Right testicular pain with tinglingness in right testicle; Dizzy spell/Dizziness/He felt like he was going to pass out; Headache; Shortness of breath; Throat swelling; Numbness and tingling to left side of face; Numbness and tingling to left side of face; This is a spontaneous report from a contactable consumer (patient) from a Pfizer sponsored program via medical information team. A 36-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: unknown) (age at the time of vaccination was 36 years) via an unspecified route of administration administered in arm right, on 10Sep2021 at 16:05 as dose 1, single for COVID-19 immunisation. The patient medical history was reported as none. Concomitant medication was not reported. The consumer clarified as, the first thing was, he stayed there observation after getting the vaccine for 15 minutes (10Sep2021). He was not having much happening then. However, by the time he got home he had throat swelling, numbness, and tingling to the left side of the face. His wife had to give him Benadryl and he took that because he was short of breath as well, but he was able to get through it. He initially stated this lasted an hour or so, but then stated it was also severe the day after the vaccine. He did not know how much Benadryl he took. He also added, the day he got the vaccine had dizziness. The dizziness started by the time he got home and he lives about 5 minutes from where he got the vaccine. He confirmed at this time the dizziness has gone away, but he had another episode of dizziness the day after the vaccine as well. The dizziness was not consistently. The last day he a dizzy spell it was a light spell. He had the spells up until three days. The second day he felt like he was going to pass out. He has not had the dizziness since about three days after the vaccine. The following day he had other symptoms (11Sep2021). The day after the vaccine he started to have kidney low back pain, right testicular pain with tinglingness in right testicle. This feeling had not subsided. However, it was not severe right now. He also had a headache the day he got the vaccine. The headache continued into the day after, and he had a headache all day on 11Sep2021. The most dizziness happened on this day, 11Sep2021, with one episode of him feeling like he will pass out. Therapeutic measures were taken as a result of shortness of breath, throat swelling, numbness and tingling to left side of face, numbness and tingling to left side of face. No Emergency or physician visits due to the events and he had a doctors appointment scheduled. The outcome of the event shortness of breath and dizzy spell/dizziness was recovered on unspecified date of Sep2021. The outcome of event kidney low back pain and right testicular pain with tinglingness in right testicle was recovering. The outcome of the event throat swelling, numbness, tingling to left side of face and headache were unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Tender and painful; Pain under arm on the side where she had gotten the vaccine; Enlarged lymph node that was tender, swollen, and painful.; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of LYMPH NODE PAIN (Tender and painful), VACCINATION SITE PAIN (Pain under arm on the side where she had gotten the vaccine) and LYMPHADENOPATHY (Enlarged lymph node that was tender, swollen, and painful.) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     Medical history was not provided by the Reporter.  Concomitant products included PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]) for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced LYMPH NODE PAIN (Tender and painful), VACCINATION SITE PAIN (Pain under arm on the side where she had gotten the vaccine) and LYMPHADENOPATHY (Enlarged lymph node that was tender, swollen, and painful.). At the time of the report, LYMPH NODE PAIN (Tender and painful) was resolving and VACCINATION SITE PAIN (Pain under arm on the side where she had gotten the vaccine) and LYMPHADENOPATHY (Enlarged lymph node that was tender, swollen, and painful.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient took Tylenol 30-40 mins after the first dose. Treatment information was not Provided.
This case was reported by a healthcare professional and described the occurrence of sterile abscess at injection site in a male subject of unspecified age who was vaccinated with PEDIARIX (GlaxoSmithKline). Concurrent vaccination included DTAP, hepatitis B recombinant and IPV (GlaxoSmithKline) unspecified dose give at 2 months of age. On an unspecified date, at 4 months of age, the subject received unspecified dose of PEDIARIX (unknown route, unknown lot number). At an unspecified time after vaccination with PEDIARIX, the subject experienced sterile abscess at injection site. After the next vaccination with PEDIARIX the events recurred. On an unspecified date, at 6 months of age, the subject received unspecified dose of PEDIARIX (unknown route, unknown lot number). At an unspecified time after vaccination with PEDIARIX, the subject experienced sterile abscess at injection site. At the time of reporting the events were resolved. The subject received DAPTACEL (Non-GSK) for the following dose. This was of 4 cases reported by the same nurse.
Lips started to feel puffy, dry mouth, nausea, fever, chills, headache,rapid heartbeat, fast pulse, covid arm, unsteadiness
pt recv vax 4JUL96 7AM & 5JUL 11PM c/o nausea, vomiting;6JUL 6AM c/o dizziness, unable to eat x1 day;pt sx include 3inch red area, painful, hard;pt saw MD-recv inj
p/vax pt presented to MD w/what was thought to be chickenpox;on exam had scattered pink papules on trunk & extremities;a few were crusty again 7 was dx w/tinea corporis;
Patient complained of dizzines minute after the shot. Placed patent flat on the ground and raised feet.  Still light headed and diaphoretic.  Taken to hospital in ambulance 40minutes after vaccination.
Pfizer Covid-19 vaccine administered on 04/09/2022 date has been determined to be outside of the recommended stability guidelines by Pfizer and the CDC and a repeat dose is recommended.
About 1.5 hours after my child's PCV vaccination he was inconsolably crying/screaming  for 8+ hours.  He developed a fever of 101.
Pt woke up unable to move lt leg 1 month p/vax; residual side effect from vax MD dx;
Approx 2.5 hrs following DTP immun pt woke up from nap & was "very listless"; Also had 2 separate incidents of difficulty swallowing mucous; p/ 1/2 hrs back to self again; Mom denies any fever; pt had 1 dose of APAP prior to the incident
Severe sepsis with acute hypoxic respiratory failure secondary to COVID-19 infection.  He was given remdesivir and Decadron.  He completed remdesivir.
7/15/19 office visit: - Numbness/tingling of her L shoulder about 1 hr after receiving the HPV and Menactra vaccines at her WCC on 6/13 - The numbness has gotten progressively worse such that it has spread to her other shoulder, her neck and diffusely down her spine - The numbness is constant, she is experiencing pain in her muscles as well - She thinks that she has also felt more foggy since the vaccine where her brain and mouth don't feel connected. Will say things that don't make sense sometimes, her sister corroborates this - She feels dizzy on occasion without LOC - She feels more weak as well, she has dropped things a couple of times after this started 7/24/19 office visit: Pt in the clinic with her mom for follow up of reaction to HPV vaccine, vaccine was given on 6/13/19 in left deltoid, she almost immediately had numbness in her arm, neck and spine. She now notices a lump on her spin on her neck. Pt also notices some numbness in legs as well. Pt tearful in the office. She was seen in UC was given prednisone/muscle relaxer, she has not tried either, she does have a referral to Pediatric Neurology. Pt has been sick in the past, She also has severe anxiety. Pt states she has been having nausea with movement of her head and neck.
Information has been received from a registered nurse concerning a 15 year old white female with no medical history or allergies who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). On 27-MAY-2007 the patient developed rash and was seen in office on 31-MAY-2007. The patient had multiple lesions on her back and torso that were to numerous to count. It was reported that the patient was administered vaccine at other office and no records of vaccination were available. On 31-MAY-2007 the patient recovered. No medical attention was sought and no diagnostic laboratory tests were undertaken. No further information is expected. This is one of several reports received from the same source.
Pt was seen by Dr. for evaluation of multiple episodes R eye pain, writhing, crying, and light sensativity. Physical exam: No purulent drainage of R eye but obvious photophobia with slight upper and lower lid edema. R cheek noted to be flushed compared to L cheek, but no focal lesions noted. Fluorescein staining reveals obvious corneal defect. Impression: Recurrent herpes simplex (R) eye & herpes simplex keratitis Plan: Dr. spoke with Pediatric Ophthalmologist who agreed to see child urgently. Pt treated with Acyclovir 400mg p.o. QID x5days. Pt will follow up with ophthalmologist for urgent evaluation of corneal defect.
Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: throat felt scratchy without difficulty swallowing or pain-Medium, Systemic: Flushed / Sweating-Mild, Systemic: Headache-Mild, Systemic: Nausea-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: Patient started coughing almost immediately after administration of influenza vaccine.  Facial flushing, facial tightness, nausea, headache and scratchy throat were accompanying symptoms.  There were no symptoms of dyspnea or facial swelling.  I took his blood pressure and it was 96/68 with a pulse of 90, but his mother confirmed that he is an athlete.  Flushing, facial tightness and nausea symptoms abated after patient consumed water and orange juice.  Monitored for 30 minutes.
Swollen Lymph nodes under left arm; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 17Apr2021 at 10:30 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. The patient medical history included asthma. The patient previously received acetylsalicylic acid (ASPRIN) on an unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 27Mar2021 at 11:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. On 18Apr2021, the patient experienced swollen lymph nodes under left arm. Therapeutic measures were not taken as a result of the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen Lymph nodes under left arm was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Moderna COVID-19 Vaccine EUA  Headache, fatigue, dizzy, muscle soreness, chills, soreness around injection site.
Patient called 1 month later to say that his arm was painful to the point that he could not move it, pain scale of 8, and that he needed to contact his doctor due to the pain, in which he was prescribed ibuprofen for the pain. He said that at this time the pain had gotten better, but was still there and not completely gone.
, . No symptoms at the time of the vaccine had hives overnight several days later no prior history of hives or food or drug allergies. Patient went to the ED was treated and released.  Symptoms have not recurred
pain; headache; administrated a first dose of Shingrix only the adjuvant without the powder; administrated a first dose of Shingrix only the adjuvant without the powder; This case was reported by a pharmacist via call center representative and described the occurrence of pain in a 69-year-old male patient who received Herpes zoster (Shingrix) (batch number 23B54, expiry date 25th September 2022) for prophylaxis.   On 9th October 2020, the patient received the 1st dose of Shingrix. On 9th October 2020, less than a day after receiving Shingrix, the patient experienced pain, headache, inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the pain, headache, inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   It was unknown if the reporter considered the pain and headache to be related to Shingrix.  Additional deatils were provided as follows: The patient was vaccinated with 1st dose of Shingrix and experienced pain and headache. While vaccination patient administered  only the adjuvant without the powder which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. Pharmacist did not know who given just the adjuvant to patient. This case was linked with case US2020203914 as reported by same reporter. The reporter consent to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020203914:same reporter
pt recv vax 5FEB96 7 slept for 14hrs;could not be aroused
Welt at injection site. Hot to touch and itchy. Spread to lower arm  Appeared one week after injection.
11jul90 pt vax hepta b. 24 hrs later pt devel rash. pt ex peeling around fingers. rash remitted.  2nd vax with no adverse events.
I was fainted, felt down, my head hit into toilet bowl, then I woke up with bleeding on head ?
Pityriasis rosea; This is a spontaneous report from a contactable consumer or other non-HCP (patient herself). A 30-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EP7533) via an unspecified route of administration in left arm on 10Apr2021 as dose 2, single (at the age of 30-years-old) for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Patient medical history was not reported. The concomitant medications included spironolactone (SPIROLACTONE). Historical vaccine included BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EN6207) via an unspecified route of administration in right arm on 20Mar2021 as dose 1, single for COVID-19 immunization. Vaccination facility type was reported as Other. Patient did not receive any other vaccine in four weeks. Patient did not have COVID-19, prior to vaccination and was not tested for COVID-19, post vaccination. On 24Apr2021, the patient experienced Pityriasis rosea. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Patient did not receive any treatment for the adverse events. The outcome of the events was not recovered.  Follow-up (23Jul2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Ininitally began with itching and redness at injection site. Redness about half dollar size. Pt was instructed to apply ice pack, Tylenol or Benadryl to relieve symptoms. Call if worsening. Pt called office on 9/25/15 stating a rash had developed. Pt seen in office on 9/25/15 and diagnosed with shingles. Unsure if this is related?
No additional AE/PQC reported; inadvertently administered a dose of VARIVAX; This spontaneous report was received from a medical assistant and referred to a 20-month-old patient of unknown gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 28-FEB-2023 (at the 12-month-old appointment), the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection, 0.5 milliliter, (two dose series), administered for prophylaxis (lot #, expiry date, anatomical location and route of administration were not provided). On 31-AUG-2023 (at the 18-month-old appointment), the patient was inadvertently vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) injection, 0.5 milliliter (two dose series), administered for prophylaxis (lot #, expiry date, anatomical location and route of administration were not provided) (wrong product administered). The reporter had not received any information of the patient experiencing any symptoms or medical concerns.
FACIAL AND LEFT ARM ITCHING; LUMP IN THROAT. TREATED WITH BENADRYL, 50 MG PO AND SOLUMEDROL, 125 MG IM.
Patient is a 68yo F who received her first dose of Pfizer vaccine today. She developed an immediate raised nonpruritic rash to the bilateral forearms. Denied any other symptoms including swelling, throat symptoms, CP, SOB, difficulty breathing, weakness, etc. Pt states she typically will have a rash reaction to many medications, vaccinations or other environmental agents. She was given 50mg Benadryl and patient observed for 35 min total. Rash resolved. No other symptoms.
Achy; Lethargic; Fever; This case was reported by a pharmacist via call center representative and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever, pain and lethargy. On an unknown date, the outcome of the fever was recovered/resolved and the outcome of the pain and lethargy were unknown.   It was unknown if the reporter considered the fever, pain and lethargy to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not provided. The patient experienced a fever over 100 degree F for two days after the first dose of Shingrix and during that time the patient was achy and lethargic. Call notes stated that agent was filing limited report Additional details was not obtained.      Lab Comments: Lab test performed on an unknown date
Pyrexia. A nurse reported that a pt received 3rd injection of Prevnar on 3/8/01. Following vaccination the child developed a fever, generalized rash and decreased appetite. The generalized rash appeared on approximately the 4th day following vaccination. The fever lasted 3-4 days.
dizziness; lightheadedness; Nearly fainted.; nausea and the feeling may vomit,; This is a spontaneous report from a contactable consumer, the patient. A 26-years-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: er8730) via an unspecified route of administration in the left arm on 26Mar2021 at 04:00 (at the age of 26-years) as a single dose for COVID-19 immunisation. Medical history included factor V Leiden and non-diabetic hypoglycaemia. The patient had no known allergies. Concomitant medications included salicylamide, caffeine, acetylsalicylic acid (EXCEDRIN) and loperamide hydrochloride (IMODIUM) for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination the patient had not been diagnosed with COVID-19. Since having the vaccine, the patient had not been tested for COVID-19. On 26Mar2021, 15 mins after vaccination, the patient experienced severe dizziness, light-headedness and nearly fainted. This sensation came in waves for 2-3 hours, usually accompanied by nausea and the feeling that the patient may vomit, though never did. The patient reported that he still feels slightly lightheaded several days later. The patient did not receive any treatments for the events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care The clinical outcome of the dizziness, light headedness, near fainting and nausea were recovered with lasting effects at the time of this report.    No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a licensed vocational nurse refers to multiple unspecified patients of unknown age and gender. On an unknown dates, the patients were vaccinated with improperly stored doses of VAQTA (lot # L034381 exp date 21-DEC-2016) (dose and route not reported). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
After receiving the COVID-19 Moderna vaccine on 21 Jan 2021 I have had tingling in lower left leg / ankle area. I waited the 48hrs to see if the effects went away it has not. I still have tingling in the lower left leg / ankle as of 27 Jan 20201. There hasn't been any increase or decrease in the intensity of the tingling.
Information has been received from a certified nurse midwife concerning a 22 year old female with no pertinent medical history or drug reactions/allergies who on 19-JUN-2007 was vaccinated with a first dose of Gardasil "usual dose and recommended route".  Concomitant therapy included YASMIN.  On an unspecified date after receiving the vaccination the patient experienced hives all over her arms and spread over her body.  The symptoms were described as "redness of the site" and "itchy".  Medical attention was sought.  The patient took BENADRYL and the symptoms did not improve.  On 20-JUN-2007 the patient had gone to the emergency room where she was given a MEDROL DOSEPAK.  The patient was not admitted to the hospital.  On an unspecified date the patient had recovered.  At the time of reporting the second dose had not been administered.  Additional information has been requested.
Pt ran fever of 103.2 R the day p/receiving MMR vax; APAP given & improved pts sx; pt was not eating & lethargic; parents did not contact MD; On 10JAN92 parent reports pt has swollen glands but is not running a fever;
I received the vaccine at 1:30 PM on 12-08-03. That evening approx. 9:30 PM I started to vomit profusely with diarhea also. That continued thru the nite. This is Wed. the 10th & I can't take food yet. Stomach, Ribs are very sore. I have no fever but am listless & tired out. Dr. told me to drink fluids so I won't dehydrate & tylenol.
This spontaneous report as received from a Physician refers to an unspecified number of patients of unknown age and gender. On unknown date, the patients were vaccinated with improperly stored doses of PEDVAXHIB lot number: M020102, expiration date on: 09-DEC-2018. The administered doses of the vaccine were exposed to a temperature excursions of 32 °F (degrees Fahrenheit) to 35°F (degrees Fahrenheit) for 123 hours and 31 °F (degrees Fahrenheit) for colder for 35 hours (coldest 26 °F). A digital data logger was involved. No adverse events were reported. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1707USA013063: US-009507513-1707USA006851.